Cover Image

Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis

Hongchao Li,1 Wei He,2 Hongbo Lin,3 Angying Du,4 Xue Zhang,5 Han Yang,5 Shuli Qu5 1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, People's Republic of China; 2Fertility and Reproductive Medicine Centre, The Southwest Hospital of AMU, Chongqing...

Full description

Saved in:

Bibliographic Details
Main Authors:	Li H (Author), He W (Author), Lin H (Author), Du A (Author), Zhang X (Author), Yang H (Author), Qu S (Author)
Format:	Book
Published:	Dove Medical Press, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
by: Chunxia Yang, et al.
Published: (2022)

The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment
by: Zhang XQ, et al.
Published: (2021)

Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome
by: Morishita M, et al.
Published: (2012)

Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation
by: Mohammad Hasan Sheikhha, et al.
Published: (2011)

Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction
by: Munawar Hussain, et al.
Published: (2013)

Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
by: Marleen Nahuis, et al.
Published: (2009)

Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study
by: Liang Y, et al.
Published: (2024)

Urinary versus recombinant gonadotropins for ovarian stimulation in women undergoing treatment with assisted reproductive technology
by: Ameet Patki, et al.
Published: (2018)

A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study
by: Bum Chae Choi, et al.
Published: (2022)

Associations of reproductive factors with postmenopausal follicle stimulating hormone
by: Rebecca Costa, et al.
Published: (2022)

Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction
by: Y Himabindu, et al.
Published: (2013)

A multicenter phase IV study to investigate the immunogenicity of recombinant human follicle-stimulating hormone and its impact on clinical outcomes in females undergoing controlled ovarian stimulation
by: Abha Majumdar, et al.
Published: (2019)

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
by: Alessandro Conforti, et al.
Published: (2021)

Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation
by: Gottumukkala Achyuta Rama Raju, et al.
Published: (2013)

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis
by: Ezcurra Diego, et al.
Published: (2010)

Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017)
by: Human Fatemi, et al.
Published: (2021)

Hematocrit as a simple method to predict and manage ovarian hyperstimulation syndrome in assisted reproduction
by: Taswin Kaur, et al.
Published: (2015)

Follicle-Stimulating Hormone: Fertility and Beyond
Published: (2019)

The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study
by: Kuo Hsin-Chih, et al.
Published: (2009)

Prediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance level
by: Leili Safdarian, et al.
Published: (2012)

PECULIARITIES OF FOLLICLE GROWTH REGULATION IN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS IN WOMEN WITH A "POOR" OVARIAN RESPONSE
by: Эльмира Рафиковна Джалилова, et al.
Published: (2024)

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction
by: Vinita Sherwal, et al.
Published: (2010)

Arterial stiffness during controlled ovarian hyperstimulation and early pregnancy in women exposed to assisted reproduction
by: Emma von Wowern, et al.
Published: (2018)

Association of follicle stimulating hormone receptor promoter with ovarian response in IVF-ET patients
by: Wang Dan, et al.
Published: (2015)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
by: M. Kirshenbaum, et al.
Published: (2021)

Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility
by: Weghofer Andrea, et al.
Published: (2010)

Severe ovarian hyperstimulation syndrome in a case of nonmutated recurrent genuine empty follicle syndrome
by: Sumina Mannur, et al.
Published: (2021)

Reliability of follicle-stimulating hormone measurements in serum
by: Kaaks Rudolf, et al.
Published: (2003)

A study to correlate serum anti mullerian hormone, basal follicle stimulating hormone and antral follicle count in primary infertility as a measure of ovarian reserve
by: Shruthi A, et al.
Published: (2022)

Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency
by: Rinaldi L, et al.
Published: (2016)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
by: Klaus F. Bühler, et al.
Published: (2021)

Ovarian stimulation in assisted reproductive technology cycles for varied patient profiles: An Indian perspective
by: Padma Rekha Jirge, et al.
Published: (2022)

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial
by: Jared C. Robins, M.D, et al.
Published: (2020)

Poor second ovarian stimulation in cynomolgus monkeys (Macaca fascicularis) is associated with the production of antibodies against human follicle-stimulating hormone
by: Yasunari SEITA, et al.
Published: (2019)

Hormonal and genetic causes of poor response to controlled ovarian stimulation in women of late reproductive age
by: O.H. Boichuk, et al.
Published: (2022)

Infertility, Assisted Reproductive Technologies and Hormone Assays
Published: (2019)

Ovarian Hyperstimulation Syndrome
Published: (2006)

Ovarian Hyperstimulation Syndrome
Published: (2006)

Ovarian hyperstimulation syndrome
by: Pratap Kumar, et al.
Published: (2011)

Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation
by: H. Saleh, et al.
Published: (2020)